Quick Takeaways
- John Bencich has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $1,199,522.
- Recent insider filing activity is available below.
Insider Trading & Ownership of John Bencich
- Location
- Seattle, WA
- Summary
- The estimated net worth of John Bencich is at least $1,199,522 dollars as of 03 Apr 2026. John Bencich is the CHIEF FINANCIAL OFFICER of AEON Biopharma, Inc. and owns shares of AEON Biopharma, Inc. (AEON) stock worth about $830.2K. John Bencich is the CEO, Director of ACHIEVE LIFE SCIENCES, INC. and owns shares of ACHIEVE LIFE SCIENCES, INC. (ACHV) stock worth about $369.3K.
- Signature
- /s/ Alexander Wilson, as Attorney-in-Fact, for John Bencich
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow John Bencich and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: AEON Biopharma, Inc. ($830,188).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of John Bencich
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| AEON | AEON Biopharma, Inc. | Chief Financial Officer | $830,188 | 02 Apr 2026 | ||
| ACHV | ACHIEVE LIFE SCIENCES, INC. | CEO, Director | $369,334 | 16 Aug 2024 |
Insider Transactions Reported by John Bencich:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.